Clinical Trials · NCT04455750
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Alliance for Clinical Trials in Oncology
- Enrollment
- 61
- Start date
- Oct 2021
- Locations
- 414 sites, United States
- Primary endpoint
- Radiographic progression-free survival (rPFS)